Literature DB >> 20134257

Intensive insulin therapy reduces the urinary intercellular adhesion molecule-1 excretion in patients with Type 2 diabetes mellitus.

Z Sun1, S Ye, Y Qian, L Sui.   

Abstract

OBJECTIVE: To observe the change of urinary intercellular adhesion molecule-1 (ICAM-1) excretion in the patients with Type 2 diabetes mellitus (T2DM) compared to normal control group, and to investigate the effect and significance of insulin intensive therapy on the urinary ICAM-1 excretion.
METHOD: We examined the urinary ICAM-1 and creatinine (Cr) of random urine in 20 patients with T2DM and 20 normal subjects using enzyme-linked immunosorbent assay. All diabetics were given intensive insulin therapy for 2 weeks, urinary ICAM- 1 and Cr was examined once again at the end of observation.
RESULTS: Compared with the normal control group, not only the fasting blood glucose (FBG), post-prandial 2-h blood glucose (P2hBG), and glycosylated hemoglobin (HbA1c), but also the urinary ICAM-1 to urinary Cr ratio in patients with T2DM increased significantly (p<0.01). The urinary ICAM-1/urinary Cr ratio of diabetics had a positive correlation with FBG (r=0.51, p<0.01), P2hBG (r=0.496, p<0.01), and HbA1c (r=0.478, p<0.05), respectively. After 2 weeks of intensive insulin therapy in Type 2 diabetics, both the level of blood glucose and the level of urinary ICAM-1/urinary Cr ratio had a remarkable decrease compared with the basal values (p<0.01).
CONCLUSION: Intensive insulin therapy is capable of alleviating the enhanced local inflammation reaction of renal tissue under hyperglycemia state with the reduction of urinary ICAM-1 excretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20134257     DOI: 10.1007/BF03345765

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

Review 1.  Inflammation in renal disease.

Authors:  Donald G Vidt
Journal:  Am J Cardiol       Date:  2005-12-01       Impact factor: 2.778

2.  Insulin therapy in type 2 diabetes. Introduction.

Authors:  Vivian A Fonseca
Journal:  Clin Cornerstone       Date:  2007

3.  High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent.

Authors:  C W Park; J H Kim; J H Lee; Y S Kim; H J Ahn; Y S Shin; S Y Kim; E J Choi; Y S Chang; B K Bang; J W Lee
Journal:  Diabetologia       Date:  2000-12       Impact factor: 10.122

4.  Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice.

Authors:  Kazuo Kitagawa; Masayasu Matsumoto; Tsutomu Sasaki; Hiroyuki Hashimoto; Keisuke Kuwabara; Toshiho Ohtsuki; Masatsugu Hori
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

5.  Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1?

Authors:  A M Teppo; E von Willebrand; E Honkanen; J Ahonen; C Grönhagen-Riska
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

6.  Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis.

Authors:  R A Gbadegesin; S A Cotton; B M Coupes; A Awan; P E C Brenchley; N J A Webb
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

7.  Detection and quantification of soluble intercellular adhesion molecule-1 (sICAM-1) in the serum and urine of patients with bladder cancer.

Authors:  B B Shi; N Goya; H Okuda; O Ryoji; H Nakazawa; H Toma
Journal:  Int J Urol       Date:  1998-07       Impact factor: 3.369

8.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

Authors:  P Dandona; A Aljada; P Mohanty; H Ghanim; W Hamouda; E Assian; S Ahmad
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.

Authors:  J C Mamputu; G Renier
Journal:  J Leukoc Biol       Date:  2004-03-12       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.